119-HR-6993 Journalist Public Summary

Public Summary — H.R. 6993 “BEACON Act of 2026”

Headline Summary: A three‑year Department of Veterans Affairs (VA) pilot to fund rigorous, patient‑focused neurorehabilitation research and clinical trials for veterans with chronic mild traumatic brain injury (mTBI), with up to $60 million authorized through 2028.

What It Does: The bill creates two VA grant programs. First, a “TBI Innovation Grant Program” funds the design, testing, and evaluation of non‑pharmacological and other neurorehabilitation treatments for chronic mTBI, including clinician training and outreach. Second, an independent, third‑party–administered research program awards set numbers of grants each year and runs randomized, controlled clinical trials to identify evidence‑based best practices and potential standards of care. The pilot must align with VA’s Staff Sergeant Fox Suicide Prevention Grant Program to improve mental‑health outcomes and reduce suicidality linked to mTBI.

• Who’s For It: Sponsor Rep. Jack Bergman (R) and co‑sponsors Reps. Sarah Elfreth (D), Kimberlyn King‑Hinds (R), Don Davis of North Carolina (D), Derrick Van Orden (R), and Morgan Luttrell (R). They argue the VA should test promising, patient‑centered neurorehabilitation approaches with gold‑standard randomized trials and better integrate mTBI care with suicide‑prevention efforts.

• Who’s Against It: No formal opposition is listed yet. Potential concerns that could surface include:
• - Duplication or fragmentation alongside existing VA research programs;
• - Oversight and transparency when using an outside third‑party to run trials;
• - Opportunity costs if VA taps general mental‑health funds before new money arrives;
• - Risk of prematurely branding interventions as a “standard of care” before sufficient evidence accumulates;
• - Ensuring small vs. large providers can compete fairly for grants.

What’s Next: On April 16, 2026, the House Veterans’ Affairs Subcommittee on Health advanced the bill to the full committee (amended) by a 7–5 vote after holding a markup the same day. The full committee will consider it next; if approved, it can go to the House floor, then to the Senate, and ultimately to the President if both chambers pass the same text.